Featured Job
-
Job Removed or Not Found
Related Jobs
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …CDx development : Provide critical strategic and tactical regulatory guidance for CDx/IVD development and CDx submission plan for each country/region, both before and
- Merck & Co. (Rahway, NJ)
- …in biological science or related disciplineB.S., with minimum of 7 years of relevant drug development experienceM.S. with minimum of 5 years relevant drug development
- Merck & Co. (North Wales, PA)
- …as it relates to internal and external stakeholder management.-Internally, it is critical to d efine and convince k ey s takeholder s of the value and criticality of the
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …for Development : Manages multiple CMC development projects. Leads submission teams with supervision. Acts as point of contact to cross-functional teams on US/EU RA CMC
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …regulatory procedural documentation, in line with company-wide policy and relevant regulatory requirementsCoordinate with broader DS quality teams to support GRA meeting
- Eisai, Inc (Nutley, NJ)
- …The Executive Director, Regulatory Affairs will provide leadership and direction for the global regulatory aspects of Eisai's products under development and post approval
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …below with or without a reasonable accommodation.Education (from an accredited college or university)Bachelor's Degree in Computer Science, Life Science, Engineering,
- Merck & Co. (Rahway, NJ)
- …10%Flexible Work Arrangements:Not ApplicableShift:1st - DayValid Driving License:NoHazardous Material(s):n/aRequired Skills:Adaptability, Adaptability, Biodesign,
- Merck & Co. (Rahway, NJ)
- …10%Flexible Work Arrangements:Not ApplicableShift:1st - DayValid Driving License:NoHazardous Material(s):n/aRequired Skills:Adaptability, Adaptability, Biodesign,
- Tris Pharma (Monmouth Junction, NJ)
- …We have more >150 US and International patents and market several branded ADHD products in the US We also license our products in the US and ex-US markets. We have a